Nanotechnology Now - Press Release: Insights into magnetic bacteria may guide research into medical nanorobots

Home > Press > Insights into magnetic bacteria may guide research into medical nanorobots

Abstract:
Magnetotactic bacteria are a unique aquatic species which use magnetic nanoparticles as an internal compass to navigate
The configuration of the magnetic chain in these bacteria has been analysed using neutrons, explaining how the magnetic field affects its behaviour
Understanding the behaviour of the chain may lay foundations for bacterial applications such as motors in biological nanorobots, which could perform minor surgical procedures, or deliver drugs to specific places inside the body

Insights into magnetic bacteria may guide research into medical nanorobots

Grenoble, France | Posted on December 12th, 2018

Researchers have long-studied magnetotactic bacteria (MTB): aquatic microbes that have the ability to orientate themselves to magnetic fields. This unusual behaviour makes them a subject of interest for improving our understanding of biomagnetism, and potentially harnessing their abilities for future technologies, such as medical nanorobots. Neutrons have been used to explore the characteristics of this magnetism, by probing the specialised parts of the cells that are involved.

MTBs exert their magnetic navigation skills using magnetosomes – membrane-structures containing magnetic nanoparticles that the bacteria mineralise from their environment. The magnetosomes arrange in a chain that acts like a magnetic compass, allowing the bacteria to move towards the riverbeds they inhabit, using the Earth’s magnetic fields. These unusual nanoparticles have been examined with neutron beams to discover the underlying mechanisms that determine the arrangement and geometry of the chains.

An international collaboration of researchers from University of the Basque Countries, University of Cantabria and the Institut Laue Langevin (ILL), have elucidated the precise structural configuration of the magnetosomes in the MTB strain Magnetospirillum gryphiswaldense. They carried out small angle neutron scattering (SANS) on a colloid of MTB, a technique that allows them to see the magnetic microstructure of the organisms in detail in aqueous solution. The D33 instrument was employed because of its polarised neutron beam mode, which allowed the researchers to analyse both the structural components and magnetic arrangement – possible because neutrons will interact with both. Magnetic nanoparticles are central to many applications, ranging from biomedical diagnostics to data storage and even hyperthermia cancer treatments, but the magnetic structures within and in between nanoparticles are challenging to probe directly. Neutron-spin resolved (or ‘polarised’) small-angle neutron scattering is one of the few tools that can be used to investigate nanoparticles in the relevant scale.

Using SANS, researchers have gained new insight into the structure of the magnetosome chain. This was previously observed to be bent, rather than straight, yet neutron probing has helped us to explore what is happening further. Neutron probing revealed that the bends do not affect the direction of the net magnetic moment, but do cause the individual nanoparticle magnetic moment to deviate by 20 degrees from the chain axis. Once the deviation is taken into account, the interplay of the magnetic dipolar interactions between the nanoparticles, and the active assembly mechanism implemented by the bacterial proteins, explains the conformation of the chains in a helical-like shape: it is simply the lowest energy arrangement for the magnetic nanoparticles.

These findings, published in Nanoscale, facilitate a better understanding of how the chain behaviour might affect applications of MTB. They could guide the development of biological nanorobots, which may deliver drugs or perform minor surgery inside the body[1]. The magnetosome chain of the bacteria could provide directional motion within the steering system. In this case, the precise conformation of the chain would be critical for it to function correctly and navigate around the body. Nanorobots would enable minimally-invasive medical procedures to be carried out, relieving patients of much of the trauma caused by current intrusive surgical methods.

Dirk Honecker, an instrument scientist at the ILL, and co-author of the study, said: “Neutron scattering is a valuable tool for examining these magnetosomes and also other materials in great detail. Our small-angle neutron instrument D33 with its polarised beam capability allows us to analyse the magnetic interactions as well as the nanoscale structures, thanks to the magnetic moment of neutrons. With this new information, we are taking a step closer to harnessing the potential of these amazing nanoparticles produced by nature. Amongst the most exciting applications will be those involving medicine – the tiny compass in the bacteria might be used to navigate the human body, and guide nanorobots to carry out tasks in specific organs or limbs.”

The massive dynamic q-range small-angle diffractometer D33 at ILL was used in this study. You can find out more about D33 here: https://www.ill.eu/users/instruments/instruments-list/d33/description/instrument-layout/

####

About Institut Laue-Langevin (ILL)
the Institut Laue-Langevin (ILL) is an international research centre based in Grenoble, France. It has led the world in neutron-scattering science and technology for almost 40 years, since experiments began in 1972. ILL operates one of the most intense neutron sources in the world, feeding beams of neutrons to a suite of 40 high-performance instruments that are constantly upgraded. Each year 1,200 researchers from over 40 countries visit ILL to conduct research into condensed matter physics, (green) chemistry, biology, nuclear physics, and materials science. The UK, along with France and Germany is an associate and major funder of the ILL

For more information, please click here

Contacts:
Fiona Batchelor
Junior Account Executive
36 Percy Street,
London, W1T 2DH
aprilsixproof.com

t: +44(0)20 3141 2990

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: